A cross-sectional study of anemia in human immunodeficiency virus-infected patients in iran

Arch Iran Med. 2009 Mar;12(2):145-50.

Abstract

Background: Anemia is a frequent complication of infection with human immunodeficiency virus (HIV). The causes of HIV-related anemia are multifactorial. This study was conducted to evaluate the factors associated with anemia in HIV-infected patients.

Methods: A total of 642 patients with HIV/AIDS attending the HIV Clinic at Imam Khomeini Hospital in Tehran, Iran enrolled in this study. A detailed history and physical examination was done for all the patients. Investigations included CD4+ count, hemoglobin concentration, and red blood cells morphology.

Results: Among HIV-infected patients, 87% were males. The mean duration of antiretroviral therapy was 17.9+/-9.2 months. The mean (+/-SD) hemoglobin level was 12.9+/-2.31 mg/dL. Evaluation of red blood cell morphology showed macrocytosis in 11%, normocytosis plus normochromia in 41.1%, and microcytosis plus hypochromia in 47.9% of the patients. The prevalence of anemia (defined as hemoglobin<10 mg/dL) was 10.3%. Anemia was positively associated with female sex (OR=3.01), CD4 level (CD4 count of <200) (OR=3.49), and antituberculous drug administration (OR=4.57).

Conclusion: Female sex, stage of HIV infection, and antituberculous drug use were the most important factors associated with anemia in HIV-infected patients in our study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anemia / diagnosis
  • Anemia / epidemiology*
  • Anti-Retroviral Agents / therapeutic use
  • Antitubercular Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Causality
  • Child
  • Child, Preschool
  • Comorbidity
  • Cross-Sectional Studies
  • Drug Therapy, Combination
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • Humans
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Risk Factors
  • Sex Factors
  • Young Adult

Substances

  • Anti-Retroviral Agents
  • Antitubercular Agents